“…[34] As reported, as ilicon centera llows the introductiono ft wo appropriate axial ligands to inhibit the p-p stacking tendency of phthalocyanine (Pc) rings;t hus, axially substituted silicon phthalocyanines (SiPcs)h ave emerged to improve the hydrophilicity and inhibit the self-aggregation of Pcs. [32,[35][36][37][38][39] On the otherh and, axially substituted SiPc can efficiently avoid the problem of isomerization, and its simple structure provides the potentialf or clinicala pplication. [34] More importantly,S iPcs enable the introductiono ft wo small-molecular-target-based moieties at the axial positions, which may improvet he specificity to cancer and anticancer activity.F or these reasons, SiPcs are of great interest to our group for conjugating with smallmolecular-target-based drugs for targeted PDT.…”